Skip to content

Homoeopathic treatment for hypertension in patients with high uric acid

Role of individualized homoeopathic medicine in the treatment of hypertension in hyperuricemic patients: an open label, single arm interventional study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097508
Enrollment
40
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I158- Other secondary hypertension

Interventions

Intervention1: Individualized Homoeopathic Medicine: After enrolment, a detailed and comprehensive case-taking will be conducted for each patient. This will be followed by a systematic analysis and e

Sponsors

The Calcutta Homoeopathic Medical College & Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering hypertension and hyperuricemia. 2. Age between 40-65 years. 3. Patients of all sexes. 4. Patients willing to avoid other uric acid and blood pressure lowering therapies during the study period.

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular conditions requiring emergency or invasive interventions. 2. Patient having psychological or mental instability. 3. Unconscious, non-ambulatory, too ill for consultation, differently abled, terminally ill or critically ill patients, mentally disabled people. 4. Pregnant and postpartum women, nursing mothers. 5. Immune-compromised condition. 6. Already been in homoeopathic treatment for any chronic illness for the last 6 weeks. 7. Simultaneous participation in any other clinical trial.

Design outcomes

Primary

MeasureTime frame
To assess change in Systolic blood pressure (SBP) and diastolic blood pressure (DBP) along with changes in serum uric acid levels.Timepoint: At the baseline and after every 4 weeks for 12 weeks of the treatment.

Secondary

MeasureTime frame
To assess changes in quality of life using the EQ-5D-5L questionnaireTimepoint: At baseline and at 3 months.

Countries

India

Contacts

Public ContactProf Dr Himangsu Hait

The Calcutta Homoeopathic Medical College and Hospital

haitdrhimangsu@gmail.com9433565680

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026